Related Experiment Video
Updated: Jul 11, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Management of hyperkalemia in dialysis patients
Nirupama Putcha1, Michael Allon
1Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Insights
Hyperkalemia is a serious risk for end-stage renal disease patients. Dialysis is the primary treatment, while insulin and albuterol offer acute potassium reduction, and diet helps prevent recurrence.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Hyperkalemia is prevalent in end-stage renal disease (ESRD) patients.
- It can lead to dangerous electrocardiographic abnormalities.
- ESRD necessitates effective hyperkalemia management strategies.
Purpose of the Study:
- To review the management of hyperkalemia in ESRD patients.
- To discuss acute and preventive treatment options.
- To evaluate the efficacy of various interventions.
Main Methods:
- Review of current medical literature on hyperkalemia in ESRD.
- Analysis of treatments including dialysis, intravenous calcium, insulin, albuterol, bicarbonate, and cation exchange resins.
- Discussion of preventive measures like dietary compliance and medication avoidance.
Main Results:
- Dialysis is the definitive treatment for hyperkalemia in ESRD.
- Intravenous calcium stabilizes the myocardium.
- Insulin and albuterol acutely lower serum potassium by intracellular shift.
- Intravenous bicarbonate and cation exchange resins are not effective for acute potassium lowering.
- Dietary compliance and avoiding hyperkalemia-promoting medications are key preventive strategies.
- Dextrose can prevent hyperkalemia during prolonged fasting.
Conclusions:
- Effective management of hyperkalemia in ESRD involves acute treatment and prevention.
- Dialysis remains the gold standard for definitive treatment.
- Pharmacological interventions have specific roles in acute management and prevention.
Abstract:
Hyperkalemia is common in patients with end-stage renal disease, and may result in serious electrocardiographic abnormalities. Dialysis is the definitive treatment of hyperkalemia in these patients. Intravenous calcium is used to stabilize the myocardium. Intravenous insulin and nebulized albuterol lower serum potassium acutely, by shifting it into the cells. Despite their widespread use, neither intravenous bicarbonate nor cation exchange resins are effective in lowering serum potassium acutely. Prevention of hyperkalemia currently rests largely upon dietary compliance and avoidance of medications that may promote hyperkalemia. Prolonged fasting may provoke hyperkalemia, which can be prevented by administration of intravenous dextrose.
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis III: Nursing Management
Acute Kidney Injury VI: Nursing Management
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis
